Skip to main content
Top
Published in: Acta Diabetologica 3/2009

01-09-2009 | Short Communication

A fibrin gel carrier system for islet transplantation into kidney subcapsule

Authors: Jong-Yeon Lim, Byoung-Hoon Min, Byoung-Geun Kim, Hyun-Ju Han, Soo-Jin Kim, Chan-Wha Kim, Sung-Sik Han, Jun-Seop Shin

Published in: Acta Diabetologica | Issue 3/2009

Login to get access

Abstract

Islet transplantation is a promising therapeutic option for type 1 diabetes, and actively performed in the clinic as well as in the animal experiments. For the rodent experiments, islet transplantation into kidney subcapsule is widely used to assess islet quality, however, it is often difficult to do using a polyethylene tubing and fine needle because of inherent dead volume of needle and stickiness of the tubing to islets. This problem makes it difficult to interpret the physiological response to different islet doses. Here, we developed a simple fibrin gel carrier system for islet transplantation into kidney subcapsule and utilized it to determine the marginal islet mass sufficient for correction of hyperglycemia in diabetic nude mice.
Literature
1.
go back to reference Shapiro AM, Ricordi C, Hering BJ et al (2006) International trial of the Edmonton protocol for islet transplantation. N Engl J Med 355:1318–1330PubMedCrossRef Shapiro AM, Ricordi C, Hering BJ et al (2006) International trial of the Edmonton protocol for islet transplantation. N Engl J Med 355:1318–1330PubMedCrossRef
2.
go back to reference Seissler J, Schott M (2008) Generation of insulin-producing beta cells from stem cells––perspectives for cell therapy in type 1 diabetes. Horm Metab Res 40:155–161PubMedCrossRef Seissler J, Schott M (2008) Generation of insulin-producing beta cells from stem cells––perspectives for cell therapy in type 1 diabetes. Horm Metab Res 40:155–161PubMedCrossRef
3.
go back to reference Emamaullee JA, Stanton L, Schur C, Shapiro AM (2007) Caspase inhibitor therapy enhances marginal mass islet graft survival and preserves long-term function in islet transplantation. Diabetes 56:1289–1298PubMedCrossRef Emamaullee JA, Stanton L, Schur C, Shapiro AM (2007) Caspase inhibitor therapy enhances marginal mass islet graft survival and preserves long-term function in islet transplantation. Diabetes 56:1289–1298PubMedCrossRef
4.
go back to reference Emamaullee JA, Davis J, Pawlick R, Toso C, Merani S, Cai S, Tseng B, James Shapiro AM (2008) The caspase selective inhibitor EP1013 augments human islet graft function and longevity in marginal mass islet transplantation in mice. Diabetes Apr 4 [Epub ahead of print] Emamaullee JA, Davis J, Pawlick R, Toso C, Merani S, Cai S, Tseng B, James Shapiro AM (2008) The caspase selective inhibitor EP1013 augments human islet graft function and longevity in marginal mass islet transplantation in mice. Diabetes Apr 4 [Epub ahead of print]
5.
go back to reference Yang Z, Chen M, Ellett JD, Carter JD, Brayman KL, Nadler JL (2005) Inflammatory blockade improves human pancreatic islet function and viability. Am J Transplant 5:475–483PubMedCrossRef Yang Z, Chen M, Ellett JD, Carter JD, Brayman KL, Nadler JL (2005) Inflammatory blockade improves human pancreatic islet function and viability. Am J Transplant 5:475–483PubMedCrossRef
6.
go back to reference Brissova M, Shostak A, Shiota M et al (2006) Pancreatic islet production of vascular endothelial growth factor-a is essential for islet vascularization, revascularization, and function. Diabetes 55:2974–2985PubMedCrossRef Brissova M, Shostak A, Shiota M et al (2006) Pancreatic islet production of vascular endothelial growth factor-a is essential for islet vascularization, revascularization, and function. Diabetes 55:2974–2985PubMedCrossRef
7.
go back to reference Garcia-Ocana A, Takane KK, Reddy VT, Lopez-Talavera JC, Vasavada RC, Stewart AF (2003) Adenovirus-mediated hepatocyte growth factor expression in mouse islets improves pancreatic islet transplant performance and reduces beta cell death. J Biol Chem 278:343–351PubMedCrossRef Garcia-Ocana A, Takane KK, Reddy VT, Lopez-Talavera JC, Vasavada RC, Stewart AF (2003) Adenovirus-mediated hepatocyte growth factor expression in mouse islets improves pancreatic islet transplant performance and reduces beta cell death. J Biol Chem 278:343–351PubMedCrossRef
8.
go back to reference Su D, Zhang N, He J et al (2007) Angiopoietin-1 production in islets improves islet engraftment and protects islets from cytokine-induced apoptosis. Diabetes 56:2274–2283PubMedCrossRef Su D, Zhang N, He J et al (2007) Angiopoietin-1 production in islets improves islet engraftment and protects islets from cytokine-induced apoptosis. Diabetes 56:2274–2283PubMedCrossRef
9.
go back to reference Ricordi C, Gray DW, Hering BJ, Kaufman DB, Warnock GL, Kneteman NM, Lake SP, London NJ, Socci C, Alejandro R et al (1990) Islet isolation assessment in man and large animals. Acta Diabetol Lat 27(3):185–195PubMedCrossRef Ricordi C, Gray DW, Hering BJ, Kaufman DB, Warnock GL, Kneteman NM, Lake SP, London NJ, Socci C, Alejandro R et al (1990) Islet isolation assessment in man and large animals. Acta Diabetol Lat 27(3):185–195PubMedCrossRef
10.
go back to reference Andrades P, Asiedu C, Rodriguez C, Goodwin KJ, McCarn J, Thomas JM (2007) Subcutaneous pancreatic islet transplantation using fibrin glue as a carrier. Transplant Proc 39:191–192PubMedCrossRef Andrades P, Asiedu C, Rodriguez C, Goodwin KJ, McCarn J, Thomas JM (2007) Subcutaneous pancreatic islet transplantation using fibrin glue as a carrier. Transplant Proc 39:191–192PubMedCrossRef
11.
go back to reference Andrades P, Asiedu C, Rodriguez C et al (2007) Insulin secretion from pancreatic islets in fibrin glue clots at different fibrinogen and thrombin concentrations. Transplant Proc 39:1607–1608PubMedCrossRef Andrades P, Asiedu C, Rodriguez C et al (2007) Insulin secretion from pancreatic islets in fibrin glue clots at different fibrinogen and thrombin concentrations. Transplant Proc 39:1607–1608PubMedCrossRef
Metadata
Title
A fibrin gel carrier system for islet transplantation into kidney subcapsule
Authors
Jong-Yeon Lim
Byoung-Hoon Min
Byoung-Geun Kim
Hyun-Ju Han
Soo-Jin Kim
Chan-Wha Kim
Sung-Sik Han
Jun-Seop Shin
Publication date
01-09-2009
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 3/2009
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-008-0073-4

Other articles of this Issue 3/2009

Acta Diabetologica 3/2009 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.